BioCryst Pharmaceuticals Inc
Symbol: BCRX (NASDAQ)
8.03
▲ (0.25%) 0.020
Company Description:
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Key Stats
- Today's Open: $8.056
- Today's High: $8.16
- Today's Low: $7.98
- Today's Volume: 49.69K
- Yesterday Close: $8.01
- Yesterday High: $8.1
- Yesterday Low: $7.93
- Yesterday Volume: 2.60M
- Last Min Volume: 1.26K
- Last Min High: $8.03
- Last Min Low: $8.015
- Last Min VWAP: $8.01886
Company Profile
- Name: BioCryst Pharmaceuticals Inc
- Website: https://www.biocryst.com
- Listed Date: 1994-03-03
- Location: DURHAM, NC
- Market Status: Active
- CIK Number: 0000882796
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.68B
- Round Lot: 100
- Outstanding Shares: 209.92M
- Asset Type: CS
RECENT FILINGS FOR BCRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-13 | 144 | View |
| 2025-08-12 | S-8 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-07-31 | 8-K | View |
| 2025-07-28 | 4 | View |
| 2025-07-11 | 3 | View |
| 2025-07-07 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-27 | 8-K | View |
| 2025-06-25 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
Latest News on BCRX